Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2024

Papachristodoulou A, Heidegger I, Virk RK, Di Bernardo M, Kim JY, Laplaca C, et al. Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer Progression. Eur Urol. 2024;85(4):361-372.

Patel SS. NPM1-Mutated Acute Myeloid Leukemia: Recent Developments and Open Questions. Pathobiology. 2024;91(1):18-29.

Long ME, Koirala S, Sloan S, Brown-Burke F, Weigel C, Villagomez L, et al. Resistance to PRMT5-targeted therapy in mantle cell lymphoma. Blood Adv. 2024;8(1):150-163.

Omar M, Xu Z, Rand SB, Alexanderani MK, Salles DC, Valencia I, et al. Semi-Supervised, Attention-Based Deep Learning for Predicting TMPRSS2:ERG Fusion Status in Prostate Cancer Using Whole Slide Images. Mol Cancer Res. 2024;22(4):347-359.

Deochand DK, Dacic M, Bale MJ, Daman AW, Josefowicz SZ, Oliver D, et al. Mechanisms of Epigenomic and Functional Convergence Between Glucocorticoid- and IL4-Driven Macrophage Programming. bioRxiv. 2024.

Javdan B, Marwaha S, Magro C, Wassef C. Pink Papules on the Cheek. Cutis. 2024;113(1):10-17.

Solomon JP, Munoz-Zuluaga C, Slocum C, Dillard A, Cong L, Wang J, et al. Evaluation of the rapid Idylla IDH1-2 mutation assay in FFPE glioma samples. Diagn Pathol. 2024;19(1):70.

Christakis A, Nowak J, Hamilton MJ, Goldblum JR, Parrack P, Lindeman NI, et al. Molecular profiling of visible polypoid and invisible conventional intestinal-type low-grade dysplasia in patients with idiopathic inflammatory bowel disease. J Clin Pathol. 2024.

Solomon JP. Practical Considerations for Oncogenic Fusion Detection and Reporting in Solid Tumors. J Appl Lab Med. 2024;9(1):116-123.

Manzo OL, Nour J, Sasset L, Marino A, Rubinelli L, Palikhe S, et al. Rewiring Endothelial Sphingolipid Metabolism to Favor S1P Over Ceramide Protects From Coronary Atherosclerosis. Circ Res. 2024.